Free delivery for orders over 69.99€

Check order status

Become part of a community of book lovers from all over the world and get access to a whole bunch of benefits. Create an account for free

Free delivery for purchases over 69.99 €

Speedy courier 3.49 € Speedy point 3.49 € Еконт courier 3.99 € Еконтомат/Офис на Еконт 3.99 € Ekont Box 3.99 € Sameday courier 3.99 € Sameday Box 3.99 € Box Now 3.99 €

Contact

How to shop

Help

My account

▸ Empty :-(

Free delivery for orders over 69.99€

Screening for Biological Response Modifiers: Methods and Rationale

Name: Screening for Biological Response Modifiers: Methods and Rationale
Brand: Kluwer Academic Publishers
SKU: 01401284
Price: 108.76 EUR
Availability: InStock
Author: James E. Talmadge
ISBN: 9780898387124

James E. Talmadge

Isaiah J. Fidler

Robert K. Oldham

Language

English

Book Hardback

Libristo code: 01401284

Publishers Kluwer Academic Publishers

The observation in the 1950s that nitrogen mustard and other toxic chemicals could induce antitumor... Full description

Libristo code: 01401284

263 b

108.76 €

212.72 лв

In stock at our supplier Shipping in 10-13 days

Up to 30 days for returns

Customers also purchased

Das Prinzip der Eigentumsopferentschädigung im Zivilrecht und im öffentlichen Recht. Lerke Schulze-Osterloh

Paperback

89.54 € 175.12 лв

Calciatori. Enciclopedia Panini del calcio italiano

Hardback

105.75 € 206.84 лв

Sprache fördern mit allen Sinnen Ute Schröder

Paperback

9.68 € 18.94 лв

Thunder 3 T07

Paperback

12.38 € 24.21 лв

Le Psaume des psaumes Bède le Vénérable

Paperback

18.86 € 36.88 лв

"Все мысли для выхода в свет - заперты". Дневники 1930-х годов Андрей Белый

Paperback

27.72 € 54.21 лв

3 MOTETS OP13 VOIX MIXTES CHANT ALAIN FERON Book

binding.

27.51 € 53.81 лв

Lexikon der Sprichwoerter und Redensarten Band 5 (De - De ) René Dick

Paperback

41.55 € 81.27 лв

De Calamitis Et Lithanthracibus (1841) Alexander Petzholdt

Paperback

19.37 € 37.89 лв

Vorstellung Vom Weltgebaude Im Wandel Der Zeiten Svante Arrhenius

Paperback

34.09 € 66.68 лв

Impacto de los juegos matemáticos Arbresha Beka

Paperback

43.47 € 85.02 лв

Hinzir Kiz Erhan Bener

Paperback

14.92 € 29.18 лв

Die Paumgartner von Nürnberg und Augsburg. Wilhelm Krag

Paperback

49.84 € 97.49 лв

Mi primer método de piano: Aprende por colores Patricia Garcia Vargas

Paperback

12.59 € 24.62 лв

Chaos, orde en bewustzijn: Een reis door de kosmos op zoek naar bewustzijn Drs Mattees Van Dijk

Paperback

22.22 € 43.47 лв

EZ LEMAIO LA QUEMA DE MONDRAGON Juan Kruz Igerabide

Paperback

17.61 € 34.45 лв

Huile Essentielle d'Eucalyptus Camendulensis de la Region de Ouargla Mehani-M

Paperback

39.69 € 77.62 лв

Lettre de Menenius Agrippa Aux Capacites de 1848 Et Au Suffrage Universel de 1869 De Langsdorff-V

Paperback

13.10 € 25.63 лв

Histoire des politiques éducatives dans l'éducation de base au Burkina Amado Kabore

Paperback

75.44 € 147.55 лв

Curiosites Du Vieux Montmartre: Les Fontaines, Montmartre-Vignoble (Ed.1893) Charles Sellier

Paperback

14.40 € 28.16 лв

The observation in the 1950s that nitrogen mustard and other toxic chemicals could induce antitumor responses in patients with refractory lymphoma initiated a massive search for active chemotherapeutic agents. The initial observations stimulated a search for new chemotherapeutic agents which might have increased antitumor activity with less toxicity for normal tissues. To aid in the search for these new chemicals and to attempt to distinguish among the many toxic chemicals which might be candidates for clinical studies, the National Cancer Institute, the pharmaceutical industry, and the cancer research laboratories of most Western nations developed systems for "screening" drugs for antitumor activity. Perhaps the most extensive screening program was established by the National Cancer Institute (1). This screening program has evolved over the last two decades, an evolution which has been repeatedly reviewed (2-5). Various screening programs in use have examined over 500,000 compounds as potential anticancer agents. From these, there are now approximately forty anticancer drugs in clinical use. The utiliy of these compounds and their toxicities have been reviewed on many occasions. It is now apparent that more active and less toxic anticancer drugs are needed. It is also clear that the current screening programs are identifying compounds with similar levels of activity and with continuing moderate to severe toxicity (6).